| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Other (expenses) income, net | -155,367 | -65,778 | 331,263 | -125,456 |
| (loss) income before income taxes | -135,292 | 503,784 | 1,448,887 | -700,350 |
| Income tax expense | 4,456 | 1,904 | 1,904 | 1,340 |
| Net (loss) income | -139,748 | 501,880 | 1,446,983 | -701,690 |
| Basic (in dollars per share) | -0.02 | 0.06 | 0.16 | -0.09 |
| Diluted (in dollars per share) | -0.02 | 0.06 | 0.16 | -0.09 |
| Diluted weighted average common shares outstanding (in shares) | 9,045,851 | 9,031,282 | 8,980,602 | 8,164,423 |
| Weighted average common shares outstanding - basic (in shares) | 9,045,851 | 9,031,282 | 8,980,602 | 8,164,423 |
IMMUCELL CORP DE (ICCC)
IMMUCELL CORP DE (ICCC)